Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3s4q | NK0 | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.593 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.582 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.569 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.549 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.548 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.541 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.537 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.536 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.530 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.529 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.527 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.523 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.522 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.521 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.513 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.513 | |
| 3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.512 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.511 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.507 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.507 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.507 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.503 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.503 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.499 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.498 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.498 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.496 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.495 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.492 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.491 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.491 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.491 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.490 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.486 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.485 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.484 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.484 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.484 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.484 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.483 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.483 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.482 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.482 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.482 | |
| 1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.481 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.478 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.475 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.474 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.473 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.472 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.472 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.471 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.471 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.471 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.470 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.469 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.469 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.469 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.468 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.468 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 4nfn | 2KC | Tau-tubulin kinase 1 | 2.7.11.1 | 0.466 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.466 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.465 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.465 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.464 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.464 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.463 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.462 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.462 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.461 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.461 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.461 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.460 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.460 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
| 3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.459 | |
| 4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4j55 | 031 | Gag-Pol polyprotein | 3.4.23.16 | 0.459 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.458 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.457 | |
| 3el4 | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 4j5j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.457 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.457 | |
| 1ida | 0PO | Gag-Pol polyprotein | 3.4.23.47 | 0.456 | |
| 1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.456 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.455 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.455 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 1hvs | A77 | Gag-Pol polyprotein | / | 0.454 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.454 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3gi6 | D78 | Gag-Pol polyprotein | / | 0.454 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.454 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 2f3k | RO1 | Protease | / | 0.453 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.453 | |
| 2pvy | ACP | Fibroblast growth factor receptor 2 | / | 0.453 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.453 | |
| 4ye3 | G04 | Gag-Pol polyprotein | 3.4.23.16 | 0.453 | |
| 1d4l | PI9 | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3em6 | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 3fkn | FKN | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3qpj | N4I | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4j54 | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.452 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
| 1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.450 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 2aid | THK | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.450 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.450 | |
| 5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.450 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
| 3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.449 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.448 | |
| 2aqu | DR7 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 2qd7 | 065 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3ocp | CMP | cGMP-dependent protein kinase 1 | 2.7.11.12 | 0.448 | |
| 3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
| 4d9t | 0JG | Ribosomal protein S6 kinase alpha-3 | 2.7.11.1 | 0.448 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.448 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.447 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 4njt | 017 | Protease | / | 0.447 | |
| 1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.446 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
| 2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3ekp | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 3ndu | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.446 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.446 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 3och | 2MX | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 3ttp | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.445 | |
| 1kzk | JE2 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1rbm | KT5 | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.444 | |
| 1t7i | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 3dcr | KVS | Protease | / | 0.444 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.444 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.444 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 2qd8 | 065 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 2qnq | QN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
| 3nbw | TR4 | Ketohexokinase | / | 0.443 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 2f8g | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 2nnp | ROC | Protease | / | 0.442 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
| 3bgb | LJG | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.442 | |
| 3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.442 | |
| 3qp0 | NI8 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.442 | |
| 4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.442 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.441 | |
| 3nu3 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.441 | |
| 3qrs | NK8 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 3rin | I2O | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
| 4ix4 | ADP | Uncharacterized protein | / | 0.441 | |
| 1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.440 | |
| 1vik | BAY | Gag-Pol polyprotein | / | 0.440 | |
| 2r43 | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 3bx5 | 304 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.440 | |
| 4a9u | A9U | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.440 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.440 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 |